Inhibitor development against factor VIII (FVIII) is the most common complication of hemophilia A...
Inhibitor development against factor VIII (FVIII) is the most common complication of hemophilia A...
The advent of new treatment options over the last decades has markedly improved the...
Recent recommendations of core outcome sets for haemophilia highlight the need for including measures...